Guardian Bio
Guardian Bio, based in Boston, MA, is a healthcare company specializing in therapeutics, focusing on developing dendritic cell-based therapies to enhance anti-tumor activity.
Company Overview
Guardian Bio, headquartered in Boston, MA, operates within the healthcare industry, specifically in the therapeutics sub-industry. The company focuses on pioneering dendritic cell-based therapeutic products to combat cancer. By transforming stem cells from cancer patients into therapeutic dendritic cells, Guardian Bio aims to revitalize the immune system's natural ability to target and eliminate tumor cells. The company is part of the Y Combinator S22 batch and has a team size of two.
Therapeutic Approach
Guardian Bio's innovative approach involves collecting stem cells from cancer patients and converting them into dendritic cells that are specifically trained against the patient's tumor. These therapeutic dendritic cells are designed to enhance and restore the immune system's ability to combat cancer effectively. This specialized method aims to create a personalized treatment that leverages the body's natural defenses to target and destroy cancer cells.
Y Combinator and Partnerships
Guardian Bio is a part of the Y Combinator S22 batch, an accelerator known for supporting startups with potential. This backing provides Guardian Bio with valuable resources and mentorship opportunities, aiding in its development and strategic growth. Moreover, the company engages in partnerships to extend its platform capabilities beyond oncology, focusing on chronic infectious diseases and autoimmune conditions. These collaborations aim to broaden the application of their dendritic cell-based therapies.
Location and Regions Served
Based in Boston, MA, Guardian Bio serves regions primarily within the United States and across America and Canada. The strategic location in Boston's robust healthcare and biotech ecosystem provides significant advantages, including access to leading research institutions, clinical facilities, and potential collaborators in the healthcare sector.